Stereologically estimated mean nuclear volume of prostatic cancer is a reliable prognostic parameter
1997

Mean Nuclear Volume as a Prognostic Indicator in Prostatic Cancer

Sample size: 100 publication Evidence: high

Author Information

Author(s): K Arima, Y Sugimura, T Hioki, A Yamashita, J Kawamura

Primary Institution: Mie University School of Medicine

Hypothesis

The study aims to determine if stereological estimation of mean nuclear volume (MNV) can provide a reliable and objective grading system for prostatic cancer.

Conclusion

Mean nuclear volume is a reliable predictor of survival in patients with prostatic cancer.

Supporting Evidence

  • The study found a significant correlation between MNV and clinical stage.
  • MNV was the only predictor of survival time in the multivariate analysis.
  • Patients with a MNV below 257 μm3 had significantly better survival rates.

Takeaway

This study found that measuring the size of cancer cell nuclei can help doctors predict how long patients with prostate cancer might live.

Methodology

The study retrospectively analyzed clinical records and tissue specimens from 100 patients diagnosed with prostatic cancer, examining the relationship between MNV and clinical outcomes.

Potential Biases

Potential bias in histological grading due to subjective evaluation by pathologists.

Limitations

The study is retrospective and based on historical data, which may limit the applicability of the findings to current clinical practices.

Participant Demographics

Patients were newly diagnosed with prostatic cancer from 1973 to 1990, with a follow-up of 5 years or longer.

Statistical Information

P-Value

< 0.0001

Confidence Interval

1.003, 1.007

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication